Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(56 sites)
Argentina
GSK Investigational Site, Buenos Aires GSK Investigational Site, CABA GSK Investigational Site, Viedma Australia
GSK Investigational Site, Liverpool, New South Wales GSK Investigational Site, Wollongong, New South Wales Belgium
GSK Investigational Site, Brussels GSK Investigational Site, Ghent GSK Investigational Site, Leuven GSK Investigational Site, Liège Brazil
GSK Investigational Site, Natal GSK Investigational Site, Porto Alegre GSK Investigational Site, São Paulo GSK Investigational Site, Vitória Canada
GSK Investigational Site, Toronto, Ontario GSK Investigational Site, Montreal, Quebec GSK Investigational Site, Montreal, Quebec Denmark
GSK Investigational Site, Copenhagen Finland
GSK Investigational Site, Helsinki GSK Investigational Site, Tampere France
GSK Investigational Site, Montpellier GSK Investigational Site, Pierre-Bénite GSK Investigational Site, Villejuif Germany
GSK Investigational Site, München Greece
GSK Investigational Site, Athens GSK Investigational Site, Athens GSK Investigational Site, Pylaia Thessaloniki GSK Investigational Site, Thessaloniki Japan
GSK Investigational Site, Chiba GSK Investigational Site, Fukuoka GSK Investigational Site, Tokyo GSK Investigational Site, Tokyo Netherlands
GSK Investigational Site, Amsterdam GSK Investigational Site, Rotterdam Norway
GSK Investigational Site, Oslo Panama
GSK Investigational Site, Panama City GSK Investigational Site, Panama City GSK Investigational Site, Punta Pacifica Panama City Panama Poland
GSK Investigational Site, Józefów GSK Investigational Site, Warsaw South Korea
GSK Investigational Site, Seoul GSK Investigational Site, Seoul Spain
GSK Investigational Site, Barcelona GSK Investigational Site, Barcelona GSK Investigational Site, Barcelona GSK Investigational Site, Madrid GSK Investigational Site, Madrid GSK Investigational Site, Madrid GSK Investigational Site, Málaga GSK Investigational Site, Valencia GSK Investigational Site, Zaragoza Sweden
GSK Investigational Site, Stockholm Turkey (Türkiye)
GSK Investigational Site, Ankara GSK Investigational Site, Ankara GSK Investigational Site, Istanbul United Kingdom
GSK Investigational Site, Glasgow GSK Investigational Site, London